FILE PHOTO: A pedestrian passes Novartis’ Institutes for Biomedical Research FILE PHOTO: A pedestrian passes by Novartis’ Institutes for Biomedical Research in Cambridge, Massachusetts, U.S., January 2, 2020. REUTERS/Brian Snyder/File Photo Post navigation Previous: US Supreme Court rebuffs Novartis bid to revive MS drug Gilenya patent